Stay updated on Lintuzumab in CLAG-M for AML Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab in CLAG-M for AML Clinical Trial page.

Latest updates to the Lintuzumab in CLAG-M for AML Clinical Trial page
- ChecktodayChange DetectedA sitewide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference0.7%

- Check8 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedThe site release identifier in the footer was updated from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check35 days agoChange DetectedA new revision entry labeled v3.7.0 was added to the record history, indicating the study record has been updated. This reflects the latest changes made to the study’s registration information.SummaryDifference0.1%

- Check56 days agoChange DetectedThe history now includes a new revision entry 'Revision: v3.6.6' added to the list, replacing 'Revision: v3.6.5'. This reflects a recent platform update captured in the record history.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry v3.6.5 was added to the Record History, and the previous revision v3.6.4 was removed, indicating a software update reflected in the page history.SummaryDifference0.1%

Stay in the know with updates to Lintuzumab in CLAG-M for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab in CLAG-M for AML Clinical Trial page.